Recurrent Spontaneous Abortion of Immune Origin and HLA Sensitization Immunotherapy
Open Access
- 1 January 2022
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Advances in Reproductive Sciences
- Vol. 10 (01), 12-18
- https://doi.org/10.4236/arsci.2022.101002
Abstract
Introduction: Spontaneous abortion is defined as pregnancy loss before the twentieth week and Recurrent Spontaneous Abortion (RSA) is defined as at least three spontaneous and successive pregnancy losses in the same period. Among the different types of immunological causes, this study refers specifically to the alloimmune cause. Women with RSA of alloimmune cause share a greater number of Human Leukocyte Antigen (HLA) with their husbands, leading to the inhibition of the production of anti-paternal asymmetric blocking antibodies, which would protect embryonic cells. Objectives: To evaluate the effect of immunotherapy with paternal HLA-sensitizing mononuclear cells in cases of RSA through the positivity of the cross-match test and its efficacy in pregnancy success. Patients and Methods: Written consent was obtained, 12 couples with a history of RSA presenting negative cross-match were included in the study. Blood samples were collected from the couple for cross-matching and the separation of paternal mononuclear cells. Immunotherapy was performed with paternal mononuclear cells intradermally in the wives’ arms on day (D) 0, D15 and D30. After the third dose, a second evaluation of the cross- match tests was performed. Results and Discussion: The age of the wives ranged from 28 to 41 years, with a mean of 34.5 years. The twelve couples had a negative cross-match test (100%). Eleven couples (96.6%) tested positive in the cross- match test after immunotherapy. Of these, 10 (90.9%) had successful pregnancies. Immunotherapy with paternal mononuclear cells showed an excellent ability to sensitize the maternal immune system, with positive cross-match, resulting in a successful pregnancy.Keywords
This publication has 20 references indexed in Scilit:
- Alteration of Th17 and Treg cells in patients with unexplained recurrent spontaneous abortion before and after lymphocyte immunization therapyReproductive Biology and Endocrinology, 2014
- Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy lossHuman Reproduction Update, 2011
- Alteration of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband’s mononuclear cellsFertility and Sterility, 2006
- Adverse effects of intradermal allogeneic lymphocyte immunotherapy: acute reactions and role of autoimmunityHuman Reproduction, 2005
- Questioning the Th1/Th2 Paradigm in Reproduction: Peripheral Levels of IL‐12 are Down‐Regulated in Miscarriage PatientsAmerican Journal of Reproductive Immunology, 2002
- Recurrent Reproductive Wastage and Immunologic FactorsAmerican Journal of Reproductive Immunology, 2002
- Is the Paternal Mononuclear Cells’ Immunization a Successful Treatment for Recurrent Spontaneous Abortion?American Journal of Reproductive Immunology, 2000
- Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: a reviewScandinavian Journal of Rheumatology, 1998
- Allogenic leukocyte immunization after five or more miscarriages. Recurrent Miscarriage Immunotherapy Trialists GroupHuman Reproduction, 1997
- Human Placenta—An Antibody Sponge?American Journal of Reproductive Immunology, 1988